Amyris_Purple.png
Amyris Enters into Second Major Product Development and Production Agreement with Royal DSM
26 sept. 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has entered into a product development and production...
Amyris_Purple.png
Amyris to Present at Rodman & Renshaw 19th Annual Global Investment Conference on September 11, 2017
06 sept. 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the Rodman & Renshaw...
Amyris_Purple.png
Amyris Delivers Another Strong Quarter with Revenue of $25.7 Million and Product Sales Increase of 159% over 2nd Quarter of 2016
10 août 2017 16h01 HE | Amyris
Q2 2017 revenues of $25.7 million, up 168% over $9.6 million for Q2 2016Q2 2017 product sales of $12.7 million, up 159% over $4.9 million for Q2 2016Completed equity financing and exceeded target with...
Amyris_Purple.png
Amyris Announces Closing of $50 Million in Second Tranche Equity Financing – Fully Capitalized with Very Strong Business Momentum
09 août 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the closing of the second and final tranche of its previously...
Amyris_Purple.png
Amyris Announces Agreements For $50 Million in Second Tranche of Equity Financing, Exceeding Previous Target of $95 Million
03 août 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced agreements for $50 million in equity financing as part of the...
Amyris_Purple.png
Amyris to Announce Second Quarter 2017 Financial Results on Thursday, August 10, 2017
01 août 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the second quarter ended June 30, 2017 after market close on Thursday, August 10,...
Amyris_Purple.png
Amyris Biossance Launches in SEPHORA Canada Stores
26 juil. 2017 08h30 HE | Amyris
EMERYVILLE, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Biossance™, the consumer beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced that it will expand to SEPHORA in over 60 SEPHORA...
Amyris_Purple.png
Amyris Enters Into First Product Development and Production Agreement With Royal DSM For Food and Nutrition Molecule
17 juil. 2017 08h50 HE | Amyris
EMERYVILLE, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announces that it has entered into its first product development and...
Amyris_Purple.png
Amyris Partners with Queensland on Biofutures Acceleration Program in Next Step Toward Planned Development of Biorefinery
20 juin 2017 08h30 HE | Amyris; Queensland Government
EMERYVILLE, Calif. and BRISBANE, Australia, June 20, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and the Government of Queensland, Australia today...
Amyris_Purple.png
Amyris Announces Reverse Stock Split - Delivering on Strong Product Revenue Growth and Execution
06 juin 2017 08h00 HE | Amyris
EMERYVILLE, Calif., June 06, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it will effect a reverse stock split previously approved by...